Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1-16-02-272-12 | Other Identifier | The Danish Data Protection Agency |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Laboratory for Proteome Analysis and Protein Characterization, Aarhus University | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background: The pathogenetic factors underlying development of diabetic polyneuropathy (DP) remain unclear. Reduced neurotrophic stimulation has been proposed as a possible mechanism. The neurotrophic factors IGF I and II, sCD-163, NGF, VEGF and BDNF are essential for development and regeneration of the nervous system. In earlier studies reduced concentrations of IGF-I and II in blood and reduced concentrations of NGF and BDNF in muscle and skin biopsies have been found in patients with DP.
Purpose: Our purpose is to determine the concentration and biological activity of Insulin-like Growth Factor I and II (IGF-I and II), soluble Cluster of Differentiation 163 (sCD-163), Nerve Growth Factor (NGF), Vascular Endothelial Growth Factor (VEGF) and Brain-derived Neurotropic Factor (BDNF) in cerebrospinal fluid and in blood in patients with diabetes and/or nerve disease (especially diabetic polyneuropathy) as well as in healthy control subjects. We will furthermore relate the findings to peripheral nerve function. In addition the composition of the cerebrospinal fluid will be analyzed using mass spectrometry.
Hypothesis: We hypothesize that DP develops due to reduced concentration and biological activity of neurotrophic factors. We expect the concentration of IGF-I and II, VEGF, NGF and BDNF to be reduced in cerebrospinal fluid in patients with DP compared to diabetic patients without damage to the nervous system and healthy control subjects.
Methods: Study subjects consists of patients from Department of Neurology and Department of Department of Clinical Medicine (Endocrinology and Diabetes) Aarhus University Hospital, Denmark, who are having a lumbar puncture performed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with diabetic polyneuropathy | |||
| Patients with diabetes without peripheral nerve disorder | |||
| Patients with polyneuropathies not due to diabetes | |||
| Patients not suffering from diabetes or nerve disease | Control subjects | ||
| Patients with unspecified nerve disease |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Concentrations of IGF-I and II, sCD-163, VEGF, NGF and BDNF in cerebrospinal fluid and blood. | november 2012 - august 2013 |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical neurological examination including tendon reflexes, muscle strength and sensation. | november 2012 - august 2013 | |
| Isokinetic dynamometry (ankle and knee at non-dominating lower extremity, elbow and wrist at dominating upper extremity) | november 2012 - august 2013 |
| Measure | Description | Time Frame |
|---|---|---|
| Protein profile of the cerebrospinal fluid using mass spectrometry. | November 2012 - august 2013 |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients who have performed a lumbar puncture at Department of Neurology and Department of Clinical Medicine (Endocrinology and Diabetes) Aarhus University Hospital, Denmark.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mia Jørgensen, medical research year student | Contact | 9194 4232 | +45 | mia.jorgensen@studmed.au.dk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Neurology, Aarhus University Hospital | Aarhus | Aarhus | 8000 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 19696031 | Background | Andreassen CS, Jakobsen J, Flyvbjerg A, Andersen H. Expression of neurotrophic factors in diabetic muscle--relation to neuropathy and muscle strength. Brain. 2009 Oct;132(Pt 10):2724-33. doi: 10.1093/brain/awp208. Epub 2009 Aug 20. | |
| 22271730 | Background | Andersen H. Motor dysfunction in diabetes. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:89-92. doi: 10.1002/dmrr.2257. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D048909 | Diabetes Complications |
| D011115 | Polyneuropathies |
| D003920 | Diabetes Mellitus |
| D010523 | Peripheral Nervous System Diseases |
| ID | Term |
|---|---|
| D004700 | Endocrine System Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D044882 | Glucose Metabolism Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Cerebrospinal fluid, plasma and serum
| Vibration and temperature thresholds (index finger on dominating arm and great toe on non-dominating leg) | november 2012 - august 2013 |
| Nerve conduction studies: Nerve velocity, Amplitude, F-waves, Motor Unit Number Estimate (dominating arm and non-dominating leg) | November 2012 - august 2013 |
| 21695763 | Background | Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW; Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011 Oct;27(7):620-8. doi: 10.1002/dmrr.1226. |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |